A PHASE 1/2A STUDY EVALUATING THE EFFECTS OF ARO-MUC5AC INHALATION SOLUTION IN HEALTHY SUBJECTS AND PATIENTS WITH ASTHMA

Project Details

StatusFinished
Effective start/end date19/09/22 → 27/09/24

Funding

  • Arrowhead Australia ex Novotech Australia: A$10,000.00
  • Arrowhead Australia Pty Ltd: A$76,689.00